Cancer drugs are often designed to block specific molecular targets, but what happens after they enter a cell is not always well understood. A new study published in Biophotonics Discovery demonstrates how advanced imaging ...
Aug 21, 2026
0
6
Glaucoma is a neurodegenerative eye disease defined by the progressive death of nerve cells in the retina called retinal ganglion cells (RGCs) and damage to the optic nerve. It doesn't have many warning signs, so significant ...
Aug 21, 2026
0
9
What happens when young adults are asked to slash their social media use to 30 minutes a day? In a new set of studies, most did not follow through, and those who did cut back reported no greater improvement in well-being ...
Aug 21, 2026
0
9
Interviews with patients hospitalized for heart failure, caregivers, providers and organizational leaders highlighted several strengths of Mighty Heart (a major clinical trial examining the effectiveness of in-home and telehealth-enabled ...
Aug 21, 2026
0
5
A review and opinion piece published in The Lancet and led by UCL (University College London) and UCLH researchers discusses the possibility that blood transfusions may inadvertently transmit harmful brain proteins, and whether ...
Aug 21, 2026
0
6
Nature-based social prescribing can help reduce loneliness among adults living in socioeconomically vulnerable urban areas, according to a trial conducted in Barcelona by the European RECETAS consortium. Loneliness decreased ...
Aug 21, 2026
0
6
Researchers at the University of Cologne, University Hospital Cologne and the Max Planck Institute for Metabolism Research have developed a method that, for the first time, enables damage to individual cells to be precisely ...
Aug 21, 2026
0
4
Biomedical scientists have developed a new nanoscale imaging technique that allows researchers to directly see how bone-forming cells use nutrients and build bone inside the body.
Aug 21, 2026
0
4
Madison's Center for Healthy Minds (CHM), along with the UW–Madison Department of Educational Psychology and a multi-university team, has found no evidence that mindfulness-based cognitive therapy (MBCT) increases the risk ...
Aug 21, 2026
0
4
The U.S. Food and Drug Administration has authorized Aletta as the first standalone robotic device that can draw blood from a patient's arm. Marketing authorization was granted to Vitestro.
Aug 21, 2026
0
16
